查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967730

血液透析和腹膜透析市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、產品、最終用戶、地區和競爭格局分類，2021-2031年

Hemodialysis and Peritoneal Dialysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血液透析和腹膜透析市場預計將從 2025 年的 801.2 億美元成長到 2031 年的 1,199.1 億美元，複合年成長率為 6.95%。

血液透析使用外部裝置過濾血液，而腹膜透析則利用腹腔內的腹膜作為天然的內部過濾器。該市場的成長主要受末期腎功能衰竭盛行率上升的驅動，而末期腎衰竭的盛行率上升與全球人口老化以及糖尿病、高血壓等文明病的增加密切相關。這些因素使得維持生命對腎臟替代療法的需求變得至關重要，因此，無論技術如何進步，需求都將保持強勁。根據國際腎臟病學會估計，到2023年，全球將有約8.5億人患有慢性腎臟病，凸顯了該領域面臨的巨大健康負擔。

市場概覽
預測期 2027-2031
市場規模：2025年 801.2億美元
市場規模：2031年 1199.1億美元
複合年成長率：2026-2031年 6.95%
成長最快的細分市場 血液透析
最大的市場 北美洲

儘管需求強勁，但阻礙市場擴張的一大挑戰是熟練的醫療專業人員嚴重短缺，包括腎臟科醫生和透析護士，而這些專業人員是開展複雜治療所必需的。這種短缺限制了透析中心的運作能力，並限制了患者獲得治療的機會，尤其是在基礎設施本已捉襟見肘的發展中地區。此外，長期治療的高昂費用以及各地不同的報銷政策也構成了透析服務普及和發展的巨大經濟障礙。

市場促進因素

全球慢性腎臟病和末期腎功能衰竭盛行率的不斷上升是推動市場擴張的主要動力。這主要是由於糖尿病和高血壓文明病的發病率不斷攀升，這些疾病會加速腎衰竭的進展，從而不可避免地對維持生命的治療產生了持續的需求，尤其是在老齡化人口中。這種人口結構的變化要求透析網路具備強大的運作能力，以應對不斷成長的患者數量。為了說明這項需求的規模，DaVita 在其 2023 年第四季財報中指出，截至 2023 年底，其網路已為約 250,200 名患者提供透析服務，這凸顯了需要每日或每週接受維持生命治療的龐大患者群體的存在。

同時，隨著經濟實惠的居家透析療法日益普及，市場結構的重塑。醫療系統和保險公司正積極推廣居家透析，以減輕傳統機構治療的經濟負擔。同時，越來越多的患者因其便利性和更高的生活品質而選擇這種治療方法。攜帶式設備的科技進步進一步加速了這一轉變，使更多患者能夠享受居家透析的益處。根據費森尤斯醫療照護2023年非財務集團報告，截至2023年12月31日，該公司在全球擁有31,258名居家透析患者。這項轉變得到了大量投資的支持，百特國際2023年全年在美國的持續經營收入達70億美元，反映出大量資金流入腎臟護理市場。

市場挑戰

熟練醫護人員的嚴重短缺是限制全球血液透析和腹膜透析市場擴張的主要瓶頸。儘管人口結構變化持續推高腎臟替代療法的需求，但透析中心的運作能力往往並非受限於設備短缺，而是難以招募合格的醫護人員。人員短缺直接阻礙了新設施的建立，降低了現有診所的患者周轉率，並有效地抑制了高需求地區的產生收入。因此，製造商和服務提供者的成長受到限制，因為他們的技術能否被廣泛接受，很大程度上取決於能否獲得訓練有素的醫護人員來執行治療。

根據國際腎臟病學會的數據，到2024年，約64%的調查對象國家將面臨腎臟科醫師短缺，58%的國家將面臨透析護理師短缺。新興經濟體的情況尤其嚴峻，因為這些國家患者數量與臨床專業人才之間的差距最大。這場人力資源危機限制了基本醫療服務的提供，阻礙了市場充分利用慢性腎臟病病率不斷上升的機遇，減緩了整個產業的成長動能。

市場趨勢

永續和環保透析技術的興起正迅速成為該行業的重要趨勢，旨在減輕傳統腎臟治療對環境的巨大影響。由於傳統血液透析過程消耗大量資源，需要大量的水和電，製造商和服務供應商正致力於設計環保系統，以在不影響臨床品質的前提下最大限度地減少廢棄物。這項轉變的特點是實施節水通訊協定並開發節能基礎設施，以滿足全球環境、社會和管治(ESG) 標準。根據 DaVita 發布的《2024 年社區護理報告》，該公司透過節能計劃在 2024 年實現了超過 7,500 萬加侖的節水量，這充分展現了這些永續性的切實成果。

同時，穿戴式和可攜式透析設備的研發正在從根本上改變腎臟替代療法的技術框架，使治療擺脫了笨重、繁瑣且固定的基礎設施。與受報銷模式驅動的居家醫療普遍趨勢不同，這一趨勢尤其關注那些能夠使緊湊型一體化主機以移動形式提供醫院級療效的創新技術。這些進步不僅因其以患者為中心的設計而備受關注，更因其在空間和移動性至關重要的急診和亞急性臨床環境中的多功能性而備受矚目。根據Outset Medical發布的“2024年第四季度及全年財務業績報告”，該公司Tablo主機的安裝量已達到約6000台，同比成長10%，表明市場對這一新一代平台的需求強勁。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血液透析與腹膜透析市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（血液透析、腹膜透析）
    • 依產品（設備、耗材、服務）分類
    • 依最終使用者（居家照護、醫院）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血液透析與腹膜透析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血液透析與腹膜透析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血液透析和腹膜透析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血液透析和腹膜透析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血液透析與腹膜透析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球血液透析與腹膜透析市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Baxter International Inc
  • B. Braun Melsungen AG
  • Fresenius Medical Care AG
  • Medtronic, Inc
  • Asahi Kasei Medical Co., Ltd
  • Nipro Corp
  • DaVita Inc
  • Becton Dickinson & Co
  • Nikkiso Co., Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23239

The Global Hemodialysis and Peritoneal Dialysis Market is projected to grow from USD 80.12 Billion in 2025 to USD 119.91 Billion by 2031, registering a CAGR of 6.95%. While hemodialysis functions by using an external machine to filter blood, peritoneal dialysis utilizes the peritoneum within the abdomen as an internal natural filter. The market is primarily propelled by the increasing prevalence of end-stage renal disease, which is closely linked to the aging global population and the rising incidence of lifestyle-dependent conditions such as diabetes and hypertension. These factors create a fundamental need for life-sustaining renal replacement therapies, ensuring demand remains robust regardless of technological shifts. According to the International Society of Nephrology, approximately 850 million individuals globally were estimated to be affected by chronic kidney disease in 2023, underscoring the massive health burden supporting this sector.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 80.12 Billion
Market Size 2031USD 119.91 Billion
CAGR 2026-20316.95%
Fastest Growing SegmentHemodialysis
Largest MarketNorth America

Despite this strong demand, a significant challenge impeding market expansion is the acute shortage of skilled healthcare professionals, including nephrologists and specialized dialysis nurses, required to administer these complex treatments. This workforce scarcity restricts the operational capacity of dialysis centers and limits patient access to care, particularly in developing regions where infrastructure is already strained. Furthermore, the high recurring costs associated with long-term therapy and inconsistent reimbursement policies across different jurisdictions create substantial economic barriers that hinder the broader accessibility and growth of dialysis services.

Market Driver

The escalating global prevalence of chronic kidney disease and end-stage renal disease serves as the primary catalyst for market expansion, fundamentally driven by the rising incidence of diabetes and hypertension. As these lifestyle-dependent conditions accelerate the progression of renal failure, they create an unavoidable and sustained demand for life-sustaining therapies, particularly among the aging geriatric population. This demographic shift necessitates robust operational capacities within dialysis networks to manage increasing patient volumes. Illustrating the scale of this need, DaVita Inc. reported in its '4th Quarter 2023 Results' that it provided dialysis services to approximately 250,200 patients across its network by the end of 2023, highlighting the vast population requiring daily or weekly life-support treatments.

Concurrently, the market is being reshaped by a growing adoption of cost-effective home-based dialysis modalities. Healthcare systems and insurance providers are increasingly incentivizing home dialysis to alleviate the financial burden of traditional in-center treatments, while patients favor the modality for its convenience and improved quality of life. Technological advancements in portable devices have further facilitated this transition, enabling broader patient uptake. According to Fresenius Medical Care's 'Non-financial Group Report 2023', the number of their patients receiving home dialysis worldwide reached 31,258 as of December 31, 2023. This shift is supported by substantial investment; Baxter International reported that sales from continuing operations in the U.S. alone totaled $7.00 billion for the full year 2023, reflecting significant capital flow into the renal care market.

Market Challenge

The acute shortage of skilled healthcare professionals represents a critical bottleneck restricting the expansion of the global hemodialysis and peritoneal dialysis market. While demand for renal replacement therapies continues to rise due to demographic shifts, the operational capacity of dialysis centers is frequently capped by the unavailability of qualified staff rather than a lack of equipment. This workforce deficit directly impedes the establishment of new facilities and reduces patient turnover in existing clinics, effectively stalling revenue generation in high-demand areas. Consequently, manufacturers and service providers face a ceiling on growth as the adoption of their technologies depends heavily on the availability of trained personnel to administer care.

According to the International Society of Nephrology, in 2024, approximately 64% of surveyed countries reported a shortage of nephrologists, while 58% reported a deficit in dialysis nurses. This scarcity is particularly detrimental in emerging economies where the gap between patient volume and available clinical expertise is widest. By limiting the delivery of essential treatments, this human resource crisis prevents the market from fully capitalizing on the escalating prevalence of chronic kidney disease, thereby dampening overall industry momentum.

Market Trends

The emergence of sustainable and green dialysis technologies is rapidly becoming a critical trend as the industry seeks to mitigate the high environmental footprint associated with traditional renal care. Conventional hemodialysis processes are resource-intensive, consuming vast quantities of water and electricity, which drives manufacturers and service providers to engineer eco-friendly systems capable of minimizing waste without compromising clinical quality. This shift is characterized by the implementation of water conservation protocols and energy-efficient infrastructure to align with global environmental, social, and governance (ESG) standards. According to DaVita Inc.'s '2024 Community Care' report, the company saved more than 75 million gallons of water through efficiency projects in 2024, illustrating the tangible impact of these sustainability initiatives.

Simultaneously, the development of wearable and portable dialysis devices is fundamentally altering the technological framework of renal replacement therapy by decoupling treatment from heavy, stationary infrastructure. Unlike the general shift toward home care driven by reimbursement models, this trend focuses specifically on engineering innovations that allow for compact, all-in-one consoles to offer hospital-grade efficacy in mobile formats. These advancements are gaining traction not only for their patient-centric design but also for their versatility in acute and sub-acute clinical settings where space and mobility are premium assets. According to Outset Medical, Inc.'s 'Fourth Quarter and Full Year 2024 Financial Results', the installed base for its Tablo console reached nearly 6,000 units, representing a 10 percent growth in 2024, signaling a robust market appetite for these next-generation platforms.

Key Market Players

  • Baxter International Inc
  • B. Braun Melsungen AG
  • Fresenius Medical Care AG
  • Medtronic, Inc
  • Asahi Kasei Medical Co., Ltd
  • Nipro Corp
  • DaVita Inc
  • Becton Dickinson & Co
  • Nikkiso Co., Ltd

Report Scope

In this report, the Global Hemodialysis and Peritoneal Dialysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemodialysis and Peritoneal Dialysis Market, By Type

  • Hemodialysis
  • Peritoneal Dialysis

Hemodialysis and Peritoneal Dialysis Market, By Product

  • Devices
  • Consumables
  • Services

Hemodialysis and Peritoneal Dialysis Market, By End user

  • Home-based
  • Hospital-based

Hemodialysis and Peritoneal Dialysis Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hemodialysis and Peritoneal Dialysis Market.

Available Customizations:

Global Hemodialysis and Peritoneal Dialysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hemodialysis and Peritoneal Dialysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Hemodialysis, Peritoneal Dialysis)
    • 5.2.2. By Product (Devices, Consumables, Services)
    • 5.2.3. By End user (Home-based, Hospital-based)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Hemodialysis and Peritoneal Dialysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product
    • 6.2.3. By End user
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hemodialysis and Peritoneal Dialysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End user
    • 6.3.2. Canada Hemodialysis and Peritoneal Dialysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End user
    • 6.3.3. Mexico Hemodialysis and Peritoneal Dialysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End user

7. Europe Hemodialysis and Peritoneal Dialysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product
    • 7.2.3. By End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End user
    • 7.3.2. France Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End user
    • 7.3.3. United Kingdom Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End user
    • 7.3.4. Italy Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End user
    • 7.3.5. Spain Hemodialysis and Peritoneal Dialysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End user

8. Asia Pacific Hemodialysis and Peritoneal Dialysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By End user
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End user
    • 8.3.2. India Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End user
    • 8.3.3. Japan Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End user
    • 8.3.4. South Korea Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End user
    • 8.3.5. Australia Hemodialysis and Peritoneal Dialysis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End user

9. Middle East & Africa Hemodialysis and Peritoneal Dialysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product
    • 9.2.3. By End user
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hemodialysis and Peritoneal Dialysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End user
    • 9.3.2. UAE Hemodialysis and Peritoneal Dialysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End user
    • 9.3.3. South Africa Hemodialysis and Peritoneal Dialysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End user

10. South America Hemodialysis and Peritoneal Dialysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product
    • 10.2.3. By End user
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hemodialysis and Peritoneal Dialysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End user
    • 10.3.2. Colombia Hemodialysis and Peritoneal Dialysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End user
    • 10.3.3. Argentina Hemodialysis and Peritoneal Dialysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hemodialysis and Peritoneal Dialysis Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Baxter International Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. B. Braun Melsungen AG
  • 15.3. Fresenius Medical Care AG
  • 15.4. Medtronic, Inc
  • 15.5. Asahi Kasei Medical Co., Ltd
  • 15.6. Nipro Corp
  • 15.7. DaVita Inc
  • 15.8. Becton Dickinson & Co
  • 15.9. Nikkiso Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer